Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention [Coronary Interventions]

Conclusions—
Among patients in the CHAMPION trials with a prior cerebrovascular event at least 1 year before the percutaneous coronary intervention, the efficacy and bleeding profile of cangrelor compared with clopidogrel was similar to that in the overall trial.

Source: Circulation: Cardiovascular Interventions - December 29, 2016 Category: Cardiology Authors: Sawlani, N. N., Harrington, R. A., Stone, G. W., Steg, P. G., Gibson, C. M., Hamm, C. W., Price, M. J., Prats, J., Deliargyris, E. N., Mahaffey, K. W., White, H. D., Bhatt, D. L. Tags: Percutaneous Coronary Intervention, Pharmacology, Ischemic Stroke, Transient Ischemic Attack (TIA) Coronary Interventions Source Type: research